K. W. Pratz Et Al. , "Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia," BLOOD CANCER JOURNAL , vol.12, no.4, 2022
Pratz, K. W. Et Al. 2022. Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia. BLOOD CANCER JOURNAL , vol.12, no.4 .
Pratz, K. W., Panayiotidis, P., Recher, C., Wei, X., Jonas, B. A., Montesinos, P., ... Ivanov, V.(2022). Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia. BLOOD CANCER JOURNAL , vol.12, no.4.
Pratz, Keith Et Al. "Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia," BLOOD CANCER JOURNAL , vol.12, no.4, 2022
Pratz, Keith W. Et Al. "Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia." BLOOD CANCER JOURNAL , vol.12, no.4, 2022
Pratz, K. W. Et Al. (2022) . "Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia." BLOOD CANCER JOURNAL , vol.12, no.4.
@article{article, author={Keith W. Pratz Et Al. }, title={Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia}, journal={BLOOD CANCER JOURNAL}, year=2022}